Roche Holding (Saridon) Overview

  • Founded
  • 1933
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Roche Holding (Saridon) General Information

Description

An analgesic combination indicated for the management of headache. The brand is a prescription medicine in a tablet form containing 150 milligram of propyphenazone, 250 milligram of paracetamol and 55 milligram of caffeine.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Basel
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Holding (Saridon) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche Holding (Saridon)‘s full profile, request access.

Request a free trial

Roche Holding (Saridon) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche Holding (Saridon)‘s full profile, request access.

Request a free trial